Print Page   |   Sign In   |   Join!
News & Press: Legislative and Regulatory News

Legislative Committee Update July 2019

Monday, July 22, 2019  
Share |

Members of the PSHP Legislative committee and other PSHP members and our officers continue to engage and address issues important to pharmacists and pharmacy technicians with our legislators and the PA Board of Pharmacy members and staff. Here are some highlights:

 

Board of Pharmacy

  • PSHP routinely has 2-3 members present at every board meeting. If you have students or residents who would like to join us for a meeting, please let us know. Meetings typically last from 9am to noon; often with a regulatory work session to follow.
  • Compounding Regulations: After many years of work by the Board, with significant input by PSHP, the compounding regulations have been finalized and were published in the Pennsylvania Bulletin on 6/22/19. They become effective immediately. Board inspectors have received training on USP 797.
    • At the request of the SBOP, PSHP has submitted questions from our members for the board to address on the regulations. The regulations enable the Board to enforce USP compounding standards with the most important being USP chapters 795, 797 and 800. Questions: send to PSHP for Christine Roussel to review and submit to the SBOP.
    • The PSHP Compounding Summit in April and the USP797 update by Patti Kienle on July 23 were focused to assist members with compliance.
  • New Facility and Facility renovation submissions to the Board. PSHP is working with SBOP staff to develop a FAQ document for hospitals. This is especially important as many hospitals are planning renovations to comply with USP standards. Questions to be addressed? Submit to Steve Sheaffer at s.sheaff@usciences.eduLicensure applications: PSHP has heard of few problems this year including residents coming from out of state. Feedback from Board staff indicate things have gone much better this year. Let us know if your experience is otherwise.

 

PSHP Legislative Day

Being planned for fall 2019. Date being finalized. Please join us in Harrisburg to advocate for and advance pharmacy practice in hospitals and health systems.

Technician Bill: HB770

  • Pennsylvania is one of 4 states where there is no requirement for licensure, registration and/or certification of pharmacy technicians.  See map provided by The Emily Jerry Foundation
  •  PSHP has been actively working with bill Sponsor Rep. DeLuca and his staff to successfully move this bill through the House Professional Licensure Committee and then be passed by the House of Representatives.
  • The Bill has been referred to the Senate Consumer Protection and Professional Licensure Committee. The PSHP focus now is lobbying committee Chair Senator Tomlinson to move the bill in the Committee. PSHP members are encouraged to contact Senator Tomlinson and other committee members and ask them to move the bill forward.

Key components of HB770 include:

  • Pharmacy Technicians will be registered by the PA Board of Pharmacy (SBOP)
    • A fee will be established for initial registration and renewal
    • Technicians will complete a criminal background check at the time of initial registration
    • Applicants can be denied and a registration can be revoked based on criminal convictions and other criteria defined in the Act.
  • New pharmacy technicians will be required to successfully complete a SBOP approved training programs based on regulations to be developed by the SBOP
    • Those working as pharmacy technicians in a licensed pharmacy for more than a year will not be required to complete the training program (they will be “grandfathered” as a registered pharmacy technicians)
    • Pharmacy technicians are required to work under the direct and immediate supervisor of a licensed pharmacist. The bill states that "Direct and immediate personal supervision" means:

(i)  Review by the pharmacist of the prescription or drug order prior to dispensing.

(ii)  Verification by the pharmacist of the final product.

(iii)  Immediate availability of the pharmacist on the premises to direct the work of the supervised individual and to respond to questions or problems.

 

PSHP is monitoring and/or developing positions on a number of other bills including:

SB 112 Limiting opioid prescribing to 7 days.

SB 223 Allowing EMS to leave a dose pack of naloxone

SB 675 Licensing prescribers of Buprenorphine (PSHP developing a position likely to oppose)

SB 569 Limited and Restricted Use of Fentanyl—approved as amended by Senate Health and Human Services: PSHP has opposed a similar bill in the past.

HB 945: Focus is on limiting medical assistance MCOs from contracting with a PBM where their corporate ownership also owns pharmacies. Also prevents limiting access to specialty pharmacy medications. 


Membership Management Software Powered by YourMembership  ::  Legal